IDH2 and astrocytoma (excluding glioblastoma): reported integrated molecular diagnosis of IDH-mutant astrocytoma versus IDH-mutant 1p19q codeleted oligodendrogliomas, with pre- and postoperative tumor volume as independent prognostic factors for survival.